The protocol describes a randomized, double-blind, placebo-controlled trial with independent sub-studies of setmelanotide in patients with obesity and at least one of the specific gene variants in the Melanocortin-4 Receptor pathway: POMC or PCSK1…
- Investigator
- Angelina V Bernier
- Status
- Accepting Candidates
- Ages
- 6 Years - 65 Years
- Sexes
- All